VP, Commercial Strategy & Launch – Immunology

Kymera Therapeutics is seeking an experienced commercial leader to drive KT-621 from late-stage development to launch and lifecycle management. You will define product vision, positioning, and differentiated value in immunology and atopic dermatitis, while leading US launch readiness and cross-functional execution.
The role requires deep immunology expertise and a proven track record in late-stage development and US commercial launches, with strong payer dynamics and physician-market

#J-18808-Ljbffr